Viatris

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company founded in 2020, uniquely positioned to bridge the traditional divide between generics and brands. Combining the best of both, Viatris aims to more holistically address healthcare needs globally, providing access at scale. The company has supplied high-quality medicines to approximately 1 billion patients around the world in 2022, demonstrating its significant global reach and impact. Viatris boasts an exceptionally extensive and diverse portfolio of medicines, supported by a one-of-a-kind global supply chain designed to reach people when and where they need them. The company has its headquarters in the United States and global centers in Pittsburgh, Shanghai, and Hyderabad, India. Viatris has a strong focus on biotechnology, healthcare, and pharmaceutical industries. With a mission to empower people worldwide to live healthier at every stage of life, Viatris is actively addressing some of the world’s most enduring health challenges. The company's emphasis on corporate social responsibility and sustainability further underscores its commitment to positive global impact. Viatris has a robust online presence, and interested parties can connect with the company through social media platforms. Additionally, for investors seeking more information, the company's investor portal provides comprehensive resources.